metformin has been researched along with ao 128 in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 17 (94.44) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Choi, DS; Chung, CH; Jang, HC; Kim, DK; Kim, DM; Kim, IJ; Kwon, HS; Lee, HW; Lee, MK; Lee, MY; Lee, SH; Park, TS; Park, YS; Shin, HK | 1 |
| Ghim, JL; Kim, DH; Kim, EJ; Kim, HS; Oh, M; Shin, JG; Shon, JH; Song, GS | 1 |
| Choi, HK; Ghim, JL; Kim, EJ; Kim, HS; Oh, M; Shin, JG; Shon, JH; Song, GS | 1 |
| Ahn, KJ; Bao, Y; Chen, L; Chuang, LM; Gao, F; Ji, Q; Jia, W; Li, P; Pang, C; Tu, Y; Xiao, X; Yang, J | 1 |
| Nagai, Y | 1 |
| Fukase, H; Harigai, M; Iida, S; Ikeda, S; Kasahara, N; Miyata, K; Ohba, Y; Saito, T; Takano, Y; Terao, K | 1 |
| Ihana-Sugiyama, N; Kakei, M; Noda, M; Sugiyama, T; Tsujimoto, T; Yamamoto-Honda, R | 1 |
| Kim, EJ; Kim, EY; Kim, HS; Oh, M; Shin, JG; Song, GS | 1 |
| Aiba, S; Imai, J; Katagiri, H; Kikuchi, K; Kohata, M; Kurosawa, S; Nakajima, T; Satake, C; Sawada, S; Takahashi, K; Takeda, K; Tsuchiya, S | 1 |
| Akkermans, RP; De Grauw, WJ; Lucassen, PL; Moelands, SV; Van de Laar, FA | 1 |
| Baik, SH; Cha, BS; Choi, SH; Jeong, IK; Kim, DM; Kim, IJ; Kim, SR; Kim, YS; Lee, IK; Lee, KW; Lee, MK; Min, KW; Oh, TJ; Park, JH; Park, JY; Park, SW; Park, TS; Son, HS; Song, YD; Yoon, KH; Yu, JM | 1 |
| Bai, R; Du, J; Liu, D; Shi, C; Wang, H; Wang, Y; Zhang, R; Zhang, X | 1 |
| Seok, H; Sohn, TS | 1 |
| Choi, SH; Oh, TJ | 1 |
| Davis, SN; Hedrington, MS | 1 |
| Chang, GY; Gu, ZC; Jiang, YH; Li, H; Lin, HW; Shen, L; Shi, FH; Xu, L | 1 |
2 review(s) available for metformin and ao 128
| Article | Year |
|---|---|
Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.
Topics: Acarbose; Blood Glucose; Cause of Death; Diabetes Mellitus, Type 2; Diet; Exercise; Fasting; Glucose Intolerance; Glycoside Hydrolase Inhibitors; Humans; Incidence; Inositol; Metformin; Prediabetic State; Randomized Controlled Trials as Topic | 2018 |
Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes.
Topics: 1-Deoxynojirimycin; Acarbose; Aged; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Inositol; Metformin; Prediabetic State | 2019 |
9 trial(s) available for metformin and ao 128
| Article | Year |
|---|---|
Comparison of acarbose and voglibose in diabetes patients who are inadequately controlled with basal insulin treatment: randomized, parallel, open-label, active-controlled study.
Topics: Acarbose; Blood Glucose; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Female; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inositol; Insulin; Male; Metformin; Middle Aged; Prospective Studies | 2014 |
Effect of voglibose on the pharmacokinetics of metformin in healthy Korean subjects.
Topics: Adult; Cross-Over Studies; Drug Interactions; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inositol; Male; Metformin; Middle Aged | 2014 |
Pharmacokinetic study of metformin to compare voglibose/metformin fixed-dose combination with coadministered voglibose and metformin.
Topics: Adult; Cross-Over Studies; Drug Combinations; Humans; Hypoglycemic Agents; Inositol; Metformin; Middle Aged; Therapeutic Equivalency; Young Adult | 2015 |
Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily pre
Topics: Acarbose; Aged; China; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Inositol; Insulin Glargine; Insulin Lispro; Male; Metformin; Middle Aged; Republic of Korea; Taiwan; Treatment Outcome | 2015 |
A Pharmacokinetic/Pharmacodynamic Drug-Drug Interaction Study of Tofogliflozin (a New SGLT2 Inhibitor) and Selected Anti-Type 2 Diabetes Mellitus Drugs.
Topics: 1-Deoxynojirimycin; Adult; Benzhydryl Compounds; Cyclohexanes; Diabetes Mellitus, Type 2; Drug Interactions; Glucose; Glucosides; Healthy Volunteers; Humans; Hypoglycemic Agents; Inositol; Male; Metformin; Middle Aged; Nateglinide; Phenylalanine; Pioglitazone; Sitagliptin Phosphate; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones; Urine; Young Adult | 2016 |
Cross-Over Study Comparing Postprandial Glycemic Increase After Addition of a Fixed-Dose Mitiglinide/Voglibose Combination or a Dipeptidyl Peptidase-4 Inhibitor to Basal Insulin Therapy in Patients with Type 2 Diabetes Mellitus.
Topics: Aged; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Humans; Hypoglycemic Agents; Inositol; Insulin; Insulin, Long-Acting; Isoindoles; Linagliptin; Male; Metformin; Middle Aged; Postprandial Period | 2017 |
Pharmacodynamic effects of voglibose administered alone, administered with metformin, and administered with metformin in a fixed-dose combination in healthy Korean subjects
.
Topics: Adult; Area Under Curve; Asian People; Blood Glucose; Cross-Over Studies; Drug Combinations; Enzyme Inhibitors; Healthy Volunteers; Humans; Hypoglycemic Agents; Inositol; Insulin; Male; Metformin; Tablets; Young Adult | 2018 |
Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial.
Topics: Adult; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Glycemic Index; Humans; Hypoglycemic Agents; Inositol; Male; Metformin; Middle Aged; Postprandial Period; Treatment Outcome; Young Adult | 2019 |
Efficacy and safety of sitagliptin added to metformin and insulin compared with voglibose in patients with newly diagnosed type 2 diabetes.
Topics: Adult; Aged; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Inositol; Male; Metformin; Middle Aged; Prospective Studies; Sitagliptin Phosphate; Treatment Outcome | 2019 |
7 other study(ies) available for metformin and ao 128
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Fixed-dose combination].
Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Inositol; Isoindoles; Metformin; Pioglitazone; Piperidines; Sulfonylurea Compounds; Thiazolidinediones; Uracil | 2015 |
Eruptive xanthomas in a patient with soft-drink diabetic ketosis and apolipoprotein E4/2.
Topics: 3-Hydroxybutyric Acid; Acetoacetates; Adolescent; Apolipoprotein E2; Apolipoprotein E4; Carbonated Beverages; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Diet, Fat-Restricted; Glycated Hemoglobin; Humans; Hypertriglyceridemia; Hypoglycemic Agents; Inositol; Insulin; Ketosis; Male; Metformin; Obesity; Xanthomatosis | 2019 |
Letter: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (
Topics: Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Inositol; Metformin | 2019 |
Response: Efficacy and Safety of Voglibose Plus Metformin in Patients with Type 2 Diabetes Mellitus: A Randomized Controlled Trial (
Topics: Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Inositol; Metformin | 2019 |
System Dynamic Model Simulates the Growth Trend of Diabetes Mellitus in Chinese Population: Implications for Future Urban Public Health Governance.
Topics: Acarbose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Metformin; Public Health | 2022 |